Market leaders Expo Technologies, Umetrics provide better PAT tool connectivity
Publication date: 18 April 2011
Author: Expo Technologies LLC
Tagged with: Expo Technologies, Lars Lindström, PAT, Paul Davies, Umetrics Inc.
Expo Technologies (St. Louis, MO) and Umetrics Inc. (San Jose, CA), industry leaders in providing tools for Pharma PAT, announce the release of Expo’s NovaMath 5.0 with capability to use models built in SIMCA- P+ by the SIMCA-QP tool. This capability allows process measurement devices controlled by Expo’s NovaPAC/NovaMath applications to run Umetrics’ SIMCA- P+ models, in real time.
“The first version of NovaPAC was installed in 2000, before the phrase PAT was even coined, so there are many process spectrometers out there that use Expo’s platform, and these can now access SIMCA-P+’s functionality,” Paul Davies, president of Expo Technologies, explained. “It has always been our goal to provide better inter-connectivity of tools for the Pharmaceutical PAT community, and this latest collaboration between Expo and Umetrics is another step towards that goal.”
SIMCA- P+ multivariate analysis software performs cluster analysis and PLS regression with classification trees. It has full OPLS® and O2PLS® functionalities and improved support for hierarchical PCA and PLS. The analysis of batch data is improved through summarized contribution plots that can be resolved to the level of individual variables.
“There are many improvements in data preprocessing, graphics, and data handling, facilitating the analysis of complex data sets for today’s pharmaceutical PAT processes,” said Lars Lindström, Umetrics general manager.
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Fast plasma sample cleanup with new Phree Phospholipid Removal Plates (21 May 2012)
- Two overall winners announced at prestigious national award ceremony in London’s Science Museum (18 May 2012)
- New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine (18 May 2012)
- NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN) (18 May 2012)
- GSK statement on tender offer to acquire Human Genome Sciences (18 May 2012)
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content